FGFR1/DDR2 inhibitor 1 (compound 11k) is an inhibitor of fibroblast growth factor receptor 1 (FGFR1) and discoindin domain receptor 2 (DDR2), with IC50 of 31.1 nM, 108.4 nM and 3.2 nM for FGFR1, KG-1, and DDR2, respectively.

Propargyl-PEG12-amine is a novel and potent PEG analogue

Biotin-PEG4-azide is a novel and potent PEG analogue

CSF1R-IN-1 is a novel and potent CSF1R inhibitor ( IC50 = 0.5 nM).

Ligupurpuroside C is a novel and potent bioactive compound

Thymopentin Acetate is a peptide compound.

Nesiritide (also known as Brain Natriuretic Peptide-32 human) is a novel and potent agonist of natriuretic peptide receptors (NPRs).

Neurotensin is a peptide compound.

CC-401 (CC401) is a potent, specific, 2nd generation and ATP-competitive anthrapyrazolone c-Jun N terminal kinase (JNK) inhibitor with potential antineoplastic activity.

ZK824190 is an orally available and specific urokinase plasminogen activator (uPA) inhibitor as a highly potential treatment for multiple sclerosis.